Form 8-K - Current report:
SEC Accession No. 0001213900-25-030353
Filing Date
2025-04-09
Accepted
2025-04-09 17:17:49
Documents
17
Period of Report
2025-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0237743-8k_aditxt.htm   iXBRL 8-K 31631
2 SECURITIES PURCHASE AGREEMENT BY AND BETWEEN EVOFEM BIOSCIENCES INC. AND ADITXT, ea023774301ex10-1_aditxt.htm EX-10.1 291975
3 FORM OF SENIOR SUBORDINATED CONVERTIBLE NOTE OF EVOFEM BIOSCIENCES, INC ea023774301ex10-2_aditxt.htm EX-10.2 271080
4 FORM OF WARRANT OF EVOFEM BIOSCIENCES, INC. ea023774301ex10-3_aditxt.htm EX-10.3 176248
5 WAIVER AGREEMENT BY AND BETWEEN EVOFEM BIOSCIENCES, INC., ADITXT, INC. AND ADIFE ea023774301ex10-4_aditxt.htm EX-10.4 20389
  Complete submission text file 0001213900-25-030353.txt   1164358

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adtx-20250408.xsd EX-101.SCH 3008
7 XBRL LABEL FILE adtx-20250408_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE adtx-20250408_pre.xml EX-101.PRE 22354
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0237743-8k_aditxt_htm.xml XML 3784
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 25825922
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)